DaVita
DVA
#2370
Rank
A$11.74 B
Marketcap
A$164.31
Share price
-1.21%
Change (1 day)
-35.61%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.54

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.83. In 2024 the company made an earnings per share (EPS) of A$16.46 an increase over its 2023 EPS that were of A$11.36.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.54-5.59%
2024A$16.4644.94%
2023A$11.3627.26%
2022A$8.92-35.56%
2021A$13.8544.1%
2020A$9.6119.7%
2019A$8.03540.48%
2018A$1.25-76.07%
2017A$5.24-19.31%
2016A$6.49242.52%
2015A$1.90-62.87%
2014A$5.1013.43%
2013A$4.508.45%
2012A$4.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
A$21.94 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.83-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
A$31.86 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.30 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA